kentucky glp-1 stomach paralysis lawsuit Trulicity [2026] GLP-1 Lawsuit | Stomach Paralysis,

Hims & Hers is one of a number of businesses that have offered compounded GLP-1 agonists to US consumers

GLP-1 receptor agonists represent a breakthrough for managing type-2 diabetes and obesity, offering metabolic benefits across multiple organ systems

On Tuesday, March 3, 2026, the Centers for Medicare and Medicaid Services (CMS) released Frequently Asked Questions (FAQs) (which he...

Adams handles employment, civil rights, and personal injury cases, with a strong record in litigation and appellate advocacy.

A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists medications that are widely prescribed for metabolic disease have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.